[144] Wix.com Ltd. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for WIX (WIX) shows a proposed sale and recent sales by an insider. The filer intends to sell 6,945 ordinary shares through Oppenheimer & Co. on 09/16/2025 with an aggregate market value of $1,186,692.15. The filer acquired 371,052 shares on 07/11/2013 by exercising options and paid cash upon exercise. The filing discloses two sales in the prior three months: 172 shares on 09/03/2025 for $24,164.30 and 58,824 shares on 09/11/2025 for $10,056,845.16. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full Rule 144 disclosure including broker, share counts, dates, and aggregate market value
• Acquisition history provided: 371,052 shares acquired via option exercise on 07/11/2013
• Recent sales disclosed with proceeds: 172 shares for $24,164.30 and 58,824 shares for $10,056,845.16

Negative

• No 10b5-1 plan date disclosed (the filing leaves the plan adoption/instruction date field blank)
• Large recent sale proceeds (58,824 shares generating $10,056,845.16) which may warrant investor attention despite no further context in the filing

Insights

Securities Analyst

TL;DR: Routine Rule 144 insider sale disclosure; provides clear quantities, dates, and proceeds.

The filing is a standard Rule 144 notice documenting an insider sale program and recent transactions. Key facts are explicit: 6,945 shares planned for sale on 09/16/2025 through Oppenheimer, prior sales totaling 59, - specifically 58,824 shares raising $10.06 million on 09/11/2025, and earlier 172-share sale. The origin of the position is stated (exercise of options on 07/11/2013 for 371,052 shares). For investors, this is factual disclosure of insider liquidity activity; the filing does not include any operational or financial performance data.

Compliance/Risk Analyst

TL;DR: Filing appears complete for Rule 144 reporting and includes required seller certification.

The form supplies necessary broker details, share counts, acquisition history, and proceeds for recent sales, meeting Rule 144 disclosure elements. The seller signs the representation about lack of undisclosed material adverse information; no date for a 10b5-1 plan is provided. There are no statements of noncompliance or caveats in the document. From a compliance perspective, the filing provides the essential data regulators and market participants require for insider sale transparency.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	6945	1186692.15	56107932	09/16/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	07/11/2013	Exercised Options	Issuer			371052	07/11/2013	Cash Upon Exercised

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shai Omer 5 YUNITSMAN ST. Tel Aviv L3 00000	Ordinary	09/03/2025	172	24164.30
Shai Omer 5 YUNITSMAN ST. Tel Aviv L3 00000	Ordinary	09/11/2025	58824	10056845.16

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for WIX (WIX) disclose?

The form discloses a proposed sale of 6,945 ordinary shares to occur on 09/16/2025 through Oppenheimer and lists prior sales of 172 shares on 09/03/2025 and 58,824 shares on 09/11/2025 with proceeds shown.

How many shares did the filer acquire and how were they acquired?

The filer acquired 371,052 shares on 07/11/2013 by exercising options and paid cash upon exercise.

What were the proceeds from the largest recent sale reported?

The filing reports proceeds of $10,056,845.16 from the sale of 58,824 shares on 09/11/2025.

Who is the broker handling the proposed sale?

The proposed sale is to be executed through Oppenheimer & Co. Inc at their New York address as listed in the filing.

Does the filing state the seller has undisclosed material information?

The seller provides the standard representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Is there evidence of a 10b5-1 trading plan in this Form 144?

No date for adoption of a 10b5-1 plan or instruction is provided in the filing; the related field is left blank.